Lack of lymphangiogenesis in human primary cutaneous melanoma: Consequences for the mechanism of lymphatic dissemination

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 1951-1957

  De Waal, Robert M W ^a   Van Altena, Margarethe C ^a   Erhard, Helmut ^b   Weidle, Ulrich H ^c   Nooijen, Peet T G A ^a   Ruiter, Dirk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH VESSEL; MELANOMA; METASTASIS; PRIORITY JOURNAL; SKIN TUMOR;

EID: 0030908726     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82:4-6
2. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
3. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
4. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995, 147:9-19
5. Carnochan P, Briggs JC, Westbury G, Davies AJ: The vascularity of cutaneous melanoma: a quantitative histologic study of lesions 0.85-1.25 mm in thickness. Br J Cancer 1991, 64:102-107
6. Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, Fine J, Cochran AJ, White WL, Rivers J, Elder DE, Wen DP, Heyman BH, Barnhill RL: Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995, 147:1049-1056
7. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI: Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma. Otolaryngol Head Neck Surg 1994, 111:417-422
8. Srivastava A, Laidler P, Davies RP, Morgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988, 133:419-423
9. Barnhill RL, Fandrey K, Levy MA, Mihm MC Jr, Hyman B: Angiogenesis and tumor progression of melanoma: quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992, 67:331-337
10. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 1994, 145:510-514
11. Rongioletti F, Miracco C, Gambini C, Pastorino A, Tosi P, Rebora A: Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. Am J Dermatopathol 1996, 18:474-477
12. Deutsch A, Lubach D, Nissen S, Neukam D: Ultrastructural studies on the invasion of melanomas in initial lymphatics of human skin. J Invest Dermatol 1992, 98:64-67
13. Fallowfield ME, Cook MG: Lymphatics in primary cutaneous melanoma. Am J Surg Pathol 1990, 14:370-374
14. Folkman J: Angiogenesis and tumor growth (correspondence). N Engl J Med 1996, 334:920-921
15. Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, Muller WA: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990, 247:1219-1222
16. Erhard H, Rietveld FJR, Bröcker EB, de Waal RMW, Ruiter DJ: Phenotype of normal cutaneous microvasculature. J Invest Dermatol 1996, 106:135-140
17. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ: Monoclonal antibody PAL-E specific for endothelium. Lab Invest 1985, 52:71-76
18. McLean IW, Nakane PK: Periodate-lysine-paraformaldehyde fixative: a new fixation for immunoelectron microscopy. J Histochem Cytochem 1974, 22:1077-1081
19. Muller WA, Ratti CM, McDonnell SL, Cohn ZA: A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 1989, 170:399-414
20. Ruiter DJ, Schlingemann RO, Rietveld FJR, de Waal RMW: Monoclonal antibody defined human endothelial antigens as vascular markers. J Invest Dermatol 1989, 93:25S-32S